{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:07:24Z","timestamp":1755220044886,"version":"3.43.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.hoc.2024.08.003","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:46:39Z","timestamp":1730803599000},"page":"89-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surgical Management of Genitourinary Cancer Liver Metastases"],"prefix":"10.1016","volume":"39","author":[{"given":"Guillaume","family":"Martel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Bertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Canil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2024.08.003_bib1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2024.08.003_bib2","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1200\/JCO.2008.20.1293","article-title":"Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma","volume":"27","author":"Motzer","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2024.08.003_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","article-title":"Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review","volume":"34","author":"Gupta","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.hoc.2024.08.003_bib5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(01)06103-7","article-title":"Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial","volume":"358","author":"Mickisch","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2024.08.003_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3892\/mco.2014.432","article-title":"Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis","volume":"3","author":"Hamada","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF00398185","article-title":"Metastatic patterns of renal carcinoma: an analysis of 687 necropsies","volume":"114","author":"Weiss","year":"1988","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0094-0143(03)00056-9","article-title":"Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease","volume":"30","author":"Janzen","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.hoc.2024.08.003_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00345-014-1293-6","article-title":"Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy","volume":"32","author":"Kim","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib11","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1245\/s10434-010-1526-x","article-title":"Surgical treatment of renal cell cancer liver metastases: a population-based study","volume":"18","author":"Ruys","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/13651820500496266","article-title":"Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience","volume":"8","author":"Aloia","year":"2006","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hoc.2024.08.003_bib13","first-page":"375","article-title":"Surgery for metachronous solitary liver metastases of renal cell carcinoma","volume":"158","author":"Stief","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1245\/ASO.2003.07.024","article-title":"Hepatic resection for metastatic renal tumors: is it worthwhile?","volume":"10","author":"Alves","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib15","first-page":"524","article-title":"Hepatic resection for noncolorectal nonendocrine liver metastases","volume":"244","author":"Adam","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00268-007-0685-9","article-title":"Liver resection for metastases from renal cell carcinoma","volume":"31","author":"Thelen","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00345-010-0560-4","article-title":"Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis","volume":"28","author":"Staehler","year":"2010","journal-title":"World J Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1477-2574.2010.00285.x","article-title":"Hepatic resection for non-colorectal, non-neuroendocrine, non-sarcoma metastasis: a single-centre experience","volume":"13","author":"Marudanayagam","year":"2011","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hoc.2024.08.003_bib19","first-page":"184","article-title":"Liver directed therapy for renal cell carcinoma","volume":"3","author":"Langan","year":"2012","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.hoc.2024.08.003_bib20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s11605-016-3115-1","article-title":"Liver resection for non-colorectal non-neuroendocrine metastases: where do we stand today compared to colorectal cancer?","volume":"20","author":"Schiergens","year":"2016","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00423-019-01852-4","article-title":"Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades","volume":"405","author":"Beetz","year":"2020","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1477-2574.2012.00495.x","article-title":"A\u00a0multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer","volume":"14","author":"Hatzaras","year":"2012","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hoc.2024.08.003_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11255-016-1226-y","article-title":"Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?","volume":"48","author":"Tonyali","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.hoc.2024.08.003_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.eururo.2011.05.038","article-title":"EAU guidelines on testicular cancer: 2011 update","volume":"60","author":"Albers","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1387\/ijdb.130031nv","article-title":"Classification, epidemiology and therapies for testicular germ cell tumours","volume":"57","author":"Vasdev","year":"2013","journal-title":"Int J Dev Biol"},{"issue":"Suppl 6","key":"10.1016\/j.hoc.2024.08.003_bib26","doi-asserted-by":"crossref","first-page":"vi125","DOI":"10.1093\/annonc\/mdt304","article-title":"Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Oldenburg","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1464-410X.2004.04999.x","article-title":"Liver metastases in germ cell cancer: defining a role for surgery after chemotherapy","volume":"94","author":"Copson","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.hoc.2024.08.003_bib28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"author":"National Comprehensive Cancer Network","key":"10.1016\/j.hoc.2024.08.003_bib29"},{"key":"10.1016\/j.hoc.2024.08.003_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MOU.0000000000000324","article-title":"Metastatic surgery in testis cancer","volume":"26","author":"Pfister","year":"2016","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.1996.14.2.454","article-title":"Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center","volume":"14","author":"Puc","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/annonc\/mdr052","article-title":"2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial","volume":"23","author":"Bachner","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib33","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ejca.2005.08.043","article-title":"Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis","volume":"42","author":"van Dijk","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hoc.2024.08.003_bib34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1634\/theoncologist.2013-0379","article-title":"Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?","volume":"19","author":"Riggs","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.hoc.2024.08.003_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10434-999-0640-0","article-title":"Hepatic resection of metastatic testicular carcinoma: a further update","volume":"6","author":"Hahn","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/1097-0142(20010801)92:3<578::AID-CNCR1357>3.0.CO;2-C","article-title":"Multimodality treatment of patients with liver metastases from germ cell tumors: the role of surgery","volume":"92","author":"Rivoire","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2024.08.003_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11605-009-0807-9","article-title":"Hepatic metastasectomy for testicular germ cell tumors: is it worth it?","volume":"13","author":"You","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib38","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.urology.2009.07.1360","article-title":"Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the surveillance, epidemiology, and end results program","volume":"75","author":"Cetin","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.hoc.2024.08.003_bib39","first-page":"17","article-title":"Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer","volume":"14","author":"So","year":"2020","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.hoc.2024.08.003_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5489\/cuaj.6136","article-title":"2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: management of castration-resistant prostate cancer (CRPC)","volume":"13","author":"Saad","year":"2019","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.hoc.2024.08.003_bib41","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.2015.65.7270","article-title":"Meta-analysis evaluating the impact of site metastasis on overall survival in men with castration-resistant prostate cancer","volume":"34","author":"Halabi","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2024.08.003_bib43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clgc.2019.03.020","article-title":"Prognostic significance of sites of visceral metastatic disease in prostate cancer: a population-based study of 12,180 patients","volume":"17","author":"Budnik","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.hoc.2024.08.003_bib44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.eururo.2014.07.020","article-title":"Impact of site of metastases on survival in patients with metastatic prostate cancer","volume":"68","author":"Gandaglia","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/pros.23645","article-title":"Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC)","volume":"78","author":"Francini","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.hoc.2024.08.003_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/EDBK_239041","article-title":"Oligometastatic prostate cancer: a shrinking subset or an opportunity for cure?","volume":"39","author":"Rao","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.hoc.2024.08.003_bib47","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00345-019-02652-7","article-title":"A\u00a0systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?","volume":"37","author":"Slaoui","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib48","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/000313481708300629","article-title":"Evolving role of hepatic resection for metastatic urologic malignancies","volume":"83","author":"Hamner","year":"2017","journal-title":"Am Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib49","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00345-019-02716-8","article-title":"Metastasectomy for visceral and skeletal oligorecurrent prostate cancer","volume":"37","author":"Battaglia","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib50","first-page":"51","article-title":"Isolated hepatic metastasis from prostate carcinoma","volume":"10","author":"Wang","year":"2017","journal-title":"Urol Case Rep"},{"key":"10.1016\/j.hoc.2024.08.003_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40792-017-0292-4","article-title":"Successful resection of a solitary metastatic liver tumor from prostate cancer 15 years after radical prostatectomy: a case report","volume":"3","author":"Kawai","year":"2017","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.hoc.2024.08.003_bib52","first-page":"1","article-title":"Solitary prostate cancer liver metastasis: an exceptional indication for liver resection","author":"Tilmans","year":"2020","journal-title":"Acta Chir Belg"},{"key":"10.1016\/j.hoc.2024.08.003_bib53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s001040050669","article-title":"Liver resection for non-colorectal, non-neuroendocrine hepatic metastases","volume":"70","author":"Lang","year":"1999","journal-title":"Chirurg"},{"key":"10.1016\/j.hoc.2024.08.003_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fonc.2012.00215","article-title":"Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer","volume":"2","author":"Ahmed","year":"2013","journal-title":"Front Oncol"},{"year":"2020","series-title":"Treatment of metastatic urothelial cancer of the bladder and urinary tract UpToDate","author":"Bellmunt","key":"10.1016\/j.hoc.2024.08.003_bib55"},{"key":"10.1016\/j.hoc.2024.08.003_bib56","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2017.09.030","article-title":"The role of surgery in metastatic bladder cancer: a systematic review","volume":"73","author":"Abufaraj","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib57","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.5489\/cuaj.787","article-title":"Age-stratified distribution of metastatic sites in bladder cancer: a population-based analysis","volume":"8","author":"Bianchi","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.hoc.2024.08.003_bib58","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/CMAR.S148856","article-title":"Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study","volume":"9","author":"Dong","year":"2017","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.hoc.2024.08.003_bib59","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1200\/JCO.1999.17.10.3173","article-title":"Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy","volume":"17","author":"Bajorin","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib60","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jnci\/djt015","article-title":"Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy","volume":"105","author":"Apolo","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2024.08.003_bib61","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"von der Maase","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib62","first-page":"631","article-title":"Surgical resection of urological tumor metastases following medical treatment","volume":"109","author":"Heidenreich","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.hoc.2024.08.003_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/BLC-170108","article-title":"Survival after metastasectomy for metastatic urothelial carcinoma: a systematic review and meta-analysis","volume":"3","author":"Patel","year":"2017","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.hoc.2024.08.003_bib64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1245\/s10434-007-9649-4","article-title":"Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases","volume":"15","author":"O\u2019Rourke","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib65","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/13651820701769701","article-title":"Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina","volume":"9","author":"Lendoire","year":"2007","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hoc.2024.08.003_bib66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00423-009-0580-y","article-title":"Non-colorectal, non-neuroendocrine, and non-sarcoma metastases of the liver: resection as a promising tool in the palliative management","volume":"395","author":"Schmelzle","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib67","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.21873\/anticanres.11140","article-title":"Metastasectomy improves survival in patients with metastatic urothelial carcinoma","volume":"36","author":"Iwamoto","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hoc.2024.08.003_bib68","first-page":"7","article-title":"Long-term disease-free survival after hepatic metastasectomy for urothelial carcinoma of the bladder: a case report and review of the literature","volume":"8","author":"Brooks","year":"2015","journal-title":"Clin Med Insights Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib69","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jamcollsurg.2011.12.048","article-title":"Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis","volume":"214","author":"Groeschl","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib70","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/jso.25228","article-title":"Assessing tools for management of noncolorectal nonneuroendocrine liver metastases: external validation of a prognostic model","volume":"118","author":"Tsang","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib71","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00423-014-1241-3","article-title":"The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review","volume":"399","author":"Fitzgerald","year":"2014","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13304-015-0315-2","article-title":"Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature","volume":"67","author":"Neri","year":"2015","journal-title":"Updates Surg"},{"key":"10.1016\/j.hoc.2024.08.003_bib73","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib74","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11864-015-0337-5","article-title":"New challenges in kidney cancer management: integration of surgery and novel therapies","volume":"16","author":"Puente Vazquez","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.hoc.2024.08.003_bib75","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/jnci\/91.10.839","article-title":"Impact of the treating institution on survival of patients with \u201cpoor-prognosis\u201d metastatic nonseminoma","volume":"91","author":"Collette","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2024.08.003_bib76","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1159\/000052520","article-title":"Metastatic urothelial cancer: evaluation of prognostic factors and change in prognosis during the last twenty years","volume":"39","author":"Sengel\u00f8v","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.hoc.2024.08.003_bib77","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11864-016-0439-8","article-title":"Oligometastatic prostate cancer","volume":"17","author":"Stevens","year":"2016","journal-title":"Curr Treat Options Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:07:38Z","timestamp":1754597258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858824000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0889858824000960"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2024.08.003","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Management of Genitourinary Cancer Liver Metastases","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2024.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}